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Abstract
Background: The small airway epithelium and alveolar macrophages are exposed to oxidants in
cigarette smoke leading to epithelial dysfunction and macrophage activation. In this context, we
asked: what is the transcriptome of oxidant-related genes in small airway epithelium and alveolar
macrophages, and does their response differ substantially to inhaled cigarette smoke?
Methods: Using microarray analysis, with TaqMan RT-PCR confirmation, we assessed oxidant-
related gene expression in small airway epithelium and alveolar macrophages from the same healthy
nonsmoker and smoker individuals.
Results: Of 155 genes surveyed, 87 (56%) were expressed in both cell populations in nonsmokers,
with higher expression in alveolar macrophages (43%) compared to airway epithelium (24%). In
smokers, there were 15 genes (10%) up-regulated and 7 genes (5%) down-regulated in airway
epithelium, but only 3 (2%) up-regulated and 2 (1%) down-regulated in alveolar macrophages.
Pathway analysis of airway epithelium showed oxidant pathways dominated, but in alveolar
macrophages immune pathways dominated.
Conclusion: Thus, the response of different cell-types with an identical genome exposed to the
same stress of smoking is different; responses of alveolar macrophages are more subdued than
those of airway epithelium. These findings are consistent with the observation that, while the small
airway epithelium is vulnerable, alveolar macrophages are not "diseased" in response to smoking.
Trial Registration: ClinicalTrials.gov ID: NCT00224185 and NCT00224198
Introduction
Oxidants, free radicals with one or more unpaired elec-
trons that are highly reactive, remove electrons from other
molecules, changing their structure and function [1]. Cig-
arette smoking, with its estimated 1014 free radicals per
puff, creates a significant oxidant burden on the epithelial
surface of the lung [2,3]. These oxidants are capable of
modifying the structure and function of cellular and non-
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cellular components, and in some cell populations, these
modifications result in cell dysfunction and injury [1,4,5].
As in other organs, the potential of oxidants to damage
pulmonary tissue is related to local antioxidant defense
mechanisms, which transform free radicals into less reac-
tive species, thereby limiting their toxic effects [6-9].
There are extensive data demonstrating that two cell pop-
ulations on the respiratory epithelial surface, the small air-
way epithelium and alveolar macrophages, are involved
in the pathogenesis of chronic obstructive pulmonary dis-
ease (COPD) associated with cigarette smoking [10-13].
The airway epithelium, endoderm-derived cells that form
a continuous single cell barrier to the bronchial tree,
responds to cigarette smoke exposure by up- and down-
regulating a variety of oxidant-related genes, but eventu-
ally succumbs to the oxidant stress of smoking, becoming
disordered in cell differentiation, repair and function [14-
18]. In contrast, alveolar macrophages, mesoderm-
derived phagocytic cells capable of releasing oxidants
when activated, respond in a hierarchical fashion to incre-
mental levels of oxidative stress, becoming activated, and
play a role in mediating damage to other cells but do not
become diseased per se [10,19,20]. In this context, we
asked the question: with the knowledge that both the
small airway epithelium and alveolar macrophages are
exposed to the same oxidant stress of cigarette smoke and
that the small airway epithelium becomes disordered and
dysfunctional while alveolar macrophages become acti-
vated, are there differences in the program of oxidant-
related gene expression in small airway epithelium and
alveolar macrophages in response to smoking?
To address this question, we capitalized on the ability to
obtain paired samples of small airway epithelium and
alveolar macrophages from healthy nonsmokers and
healthy smokers, thus circumventing the variability of
genetic diversity and differences in smoking patterns
among individuals. Using microarray gene expression
analysis we compared oxidant-related gene expression in
both cell populations for smokers and nonsmokers and
the differences in response by smoking status. The data
shows that at baseline in healthy nonsmokers, many oxi-
dant-related genes are expressed at higher levels in alveo-
lar macrophages than in small airway epithelium.
However, in healthy smokers, in response to the stress of
smoking, only a few oxidant-related genes responded in a
similar fashion between the two cell types. There were far
more smoking-induced changes in expression of oxidant-
related genes in small airway epithelium than in alveolar
macrophages This disparate response to cigarette smoking
was also observed in analysis of functional pathways
affected by smoking across all smoking responsive genes.
Oxidation-related pathways predominated only in small
airway epithelium and not in alveolar macrophages. Thus,
in the same individuals, different cell-types with an iden-
tical genome and exposed to the same oxidant stress of
cigarette smoking have very different responses. The
changes in oxidant-related gene expression of alveolar
macrophages were much less than those observed in small
airway epithelium, suggesting that the small airway epi-
thelium transcriptome is more responsive than alveolar
macrophages to oxidative stress.
Methods
Study Population
Healthy nonsmokers and healthy smokers were recruited
using local print media. The study was approved by the
Weill Cornell Medical College Institutional Review Board,
with written informed consent obtained from each indi-
vidual before enrollment. Subjects were evaluated at the
Weill Cornell NIH General Clinical Research Center and
Department of Genetic Medicine Clinical Research Facil-
ity. Individuals were determined to be healthy on the
basis of clinical history and physical examination, routine
blood screening tests, urinalysis, chest X-ray, electrocardi-
ogram and pulmonary function testing. Current smoking
status was confirmed on history, venous carboxyhemo-
globin levels, and urinalysis for nicotine levels and its
derivative cotinine.
Collection of Airway Epithelial Cells and Alveolar 
Macrophages
Small airway epithelial cells and alveolar macrophages
were collected using flexible bronchoscopy [17,19].
Smokers were asked not to smoke for 12 hr prior to the
procedure.
Small airway samples were collected from 10th to 12th
order bronchi using methods previously described [17].
Briefly, a 2 mm diameter brush was wedged in the small
airways of the right lower lobe and cells collected by gen-
tly brushing this area. These cells were subsequently col-
lected in 5 ml of BEBM medium (GIBO, Grand Island,
NY). An aliquot of this was used for cytology and differen-
tial cell count and the remainder was processed immedi-
ately for RNA extraction. Total cell number was
determined by counting on a hemocytometer. Cell viabil-
ity was estimated by Trypan Blue exclusion. Differential
cell count was assessed on sedimented cells prepared by
centrifugation (Cytospin 11; Shandon Instruments, Pitts-
burgh, PA) and stained with DiffQuik (Baxter Healthcare,
Miami, FL).
Alveolar macrophages were collected by bronchoalveolar
lavage (BAL), as previously described [19,21]. BAL fluid
was centrifuged at 1,200 rpm for 5 min, 4°C. Cells were
washed twice in RPMI 1640 containing 10% fetal bovine
serum, 50 U/ml penicillin, 50 U/ml streptomycin and 2
mM glutamine (Invitrogen, Carlsbad, CA), suspended inRespiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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10 ml medium and an aliquot of 0.5 ml was used for total
cell count, cell viability assessment and differential cell
count. The remainder of the cells were seeded in six-well
culture dishes (2 × 106 per 2 ml/well) and purified (≥97%
alveolar macrophages) by adherence at 37°C, 2 hr in a 5%
CO2  humidified incubator. Nonadherent cells were
removed by washing with RPMI 1640 before RNA extrac-
tion.
Selection of Oxidant-related Genes for Analysis
A list of oxidant-related genes was compiled from the lit-
erature and also by searching the Affymetrix associated
gene annotations [6,7,22-24]. This list of oxidant-related
genes was then categorized into major functional catego-
ries. Where multiple probe set identifications existed for a
single oxidant-related gene, the probe set with the highest
overall expression in small airway epithelium and alveo-
lar macrophages was chosen to represent this gene. Data
on all oxidant-related gene probe sets is available at the
Gene Expression Omnibus (GEO) website.
RNA Extraction and Microarray Processing and Analysis
Analyses were performed using Affymetrix (Santa Clara,
CA) microarray HG-U133 Plus 2.0 (54,675 probe sets)
and associated protocols. Total RNA was extracted from
epithelial cells and alveolar macrophages using TRIzol
(Invitrogen, Carlsbad, CA) followed by Rneasy (Qiagen,
Valencia, CA) to remove residual DNA. This process
yielded 2 to 4 μg RNA per 106 cells. An aliquot of each
RNA sample was assessed using an Agilent Bioanalyzer
(Agilent Technologies, Palo Alto, CA) to visualize and
quantify the degree of RNA integrity. The concentration
was determined using a NanoDrop ND-1000 spectropho-
tometer (NanoDrop Technologies, Wilmington, DE).
Double stranded cDNA was synthesized from 3 μg of total
RNA using the GeneChip One-Cycle cDNA Synthesis Kit,
followed by cleanup with GeneChip Sample Cleanup
Module,  in vitro transcription (IVT) reaction using the
GeneChip IVT Labeling Kit, and clean-up and quantifica-
tion of the biotin-labeled cDNA yield by spectrophoto-
metric analysis. All kits were from Affymetrix (Santa Clara,
CA). Hybridizations to test chips and the microarrays
were performed according to Affymetrix protocols, and
microarrays were processed by the Affymetrix fluidics sta-
tion and scanned with the Affymetrix GeneChip Scanner
3000 7G. Microarray quality was verified by the following
criteria: (1) RNA Integrity Number (RIN) ≥7.0; (2) 3'/5'
ratio for GAPDH ≤3; and (3) scaling factor ≤10.0[25,26].
Captured images were analyzed using the Microarray
Suite version 5.0 (MAS 5.0) algorithm (Affymetrix). These
data were normalized using GeneSpring version 6.2 soft-
ware (Agilent Technologies) per array, by dividing raw
data by the 50th percentile of all measurements.
TaqMan RT-PCR Confirmation of Microarray Gene 
Expression
cDNA was synthesized from 2 μg RNA in a 100 μl reaction
volume, using the TaqMan Reverse Transcriptase Reaction
Kit (Applied Biosystems, Foster City, CA), with random
hexamers as primers. Then two dilutions of 1:10 and
1:100 were made from each sample and duplicate wells
were run for each dilution. TaqMan PCR reactions were
carried out using pre-made kits from Applied Biosystems
and 2 μl of cDNA was used in each 25 μl reaction volume.
The oxidant-related gene expression assays were opti-
mized assays from Applied Biosystems. The endogenous
control was 18S ribosomal RNA and relative expression
levels were determined using the ΔΔCt method (Applied
Biosystems) and the average value for the nonsmokers as
the calibrator.
Functional Pathway Assessment
To further assess the hypothesis that small airway epithe-
lium is more oxidant-responsive than alveolar macro-
phages to the stress of smoking, analysis of pathways
affected by smoking was done using Ingenuity Pathways
Analysis http://www.ingenuity.com. All smoking respon-
sive genes (fold-change >1.5 up- or down-regulated, p <
0.05 with Benjamini-Hochberg multiple test correction)
were assessed using the pathway analysis program. Those
canonical pathways chosen by the software analysis pro-
gram on the basis of ratio (number of pathway genes in
the smoking responsive data set compared to the total
number of genes in the curated pathway) and significance
(-log p value) were deemed those pathways most affected
by cigarette smoking in small airway epithelium and alve-
olar macrophages.
Statistical Analysis
A Chi-squared test was used to compare the distribution
of gender and ethnicity between nonsmokers and smok-
ers. The HG-U133 Plus 2.0 microarrays were analyzed
using GeneSpring software. Average expression values for
oxidant-related genes in small airway epithelial cell sam-
ples and alveolar macrophages were calculated using nor-
malized expression levels for healthy nonsmokers and
healthy smokers. Benjamini-Hochberg correction was
applied to limit the false discovery rate. When assessing
expression in alveolar macrophages vs small airway epi-
thelium, comparisons for each oxidant-related gene were
done first per individual and then all individual ratios
were used to calculate the average fold-change in alveolar
macrophages vs airway epithelium. A paired two-tailed t
test was used to test the statistical significance of differ-
ences. When assessing the difference between smokers
and nonsmokers, fold-change was calculated from the
average expression values of smokers compared to the
average expression value of nonsmokers and an unpairedRespiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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two-tailed t test was used to test the statistical significance
of differences. Fold-change was considered statistically
significant if the magnitude of the fold-change was greater
than 1.5 and p value < 0.05, respectively. Standard error
was calculated for the fold change of smokers vs non-
smokers using the method of calculation of the standard
error for a ratio.
Web Deposition of Data
Data for the complete microarray study has been depos-
ited in the Gene Expression Omnibus (GEO) site, http://
www.ncbi.nlm.nih.gov/geo which is curated by the
National Center for Bioinformatics (NCBI). Accession
number is as follows: GSE13931.
Results
Study Population
Small airway samples and alveolar macrophages were col-
lected from 19 healthy nonsmokers and 30 healthy smok-
ers (Table 1). All individuals had no significant prior
medical history and a normal physical examination. There
were no differences between the groups with regard to age
(p > 0.5), gender (p > 0.4) or self-reported ancestry (p >
0.2). All individuals were HIV negative, with blood and
urine parameters within normal ranges. Smokers had an
average smoking history of 27 pack-yr. Urine nicotine,
urine cotinine and venous blood carboxyhemoglobin lev-
els confirmed current smoking status of these individuals.
Both populations had normal chest X-rays. Pulmonary
function testing revealed normal spirometry, lung vol-
umes and diffusing capacity for carbon monoxide in
healthy nonsmokers and healthy smokers.
Sampling of Airway Epithelium and Alveolar Macrophages
Airway epithelial cells were obtained from the small (10th
to 12th order) airways. The number of epithelial cells
recovered ranged from 2.5 to 7.8 × 106 for the nonsmokers
and 3.5 to 13.9 × 106 for the healthy smokers (p < 0.05;
Table 1). In all cases >98% of cells recovered were epithe-
lial cells. The various categories of airway epithelial cells
Table 1: Study Population for Paired Small Airway Epithelium and Alveolar Macrophage Samples1
Parameter Healthy nonsmokers Healthy smokers
Demographics
n 19 30
Sex (male/female) 15/4 22/8
Age (yr) 42 ± 2 43 ± 1
Race (B/W/H/)2 11/6/2 18/10/2
Smoking history (pack-yr) 0 27 ± 3
Urine nicotine (ng/ml) Negative 775 ± 176
Urine cotinine (ng/ml) Negative 969 ± 136
Venous CO-Hb3 0.7 ± 0.2 2.3 ± 0.4
Pulmonary function parameters4
FVC 107 ± 2 110 ± 2
FEV1 100 ± 6 110 ± 2
FEV1/FVC 80 ± 1 82 ± 1
TLC 97 ± 2 100 ± 2
DLCO 94 ± 2 100 ± 2
Small airway epithelium
Total number recovered ×106 5.1 ± 0.4 6.7 ± 0.4
% epithelial 99 ± 1 99 ± 1
% inflammatory 1 ± 1 0
Epithelial cell differential
% ciliated 73 ± 2 76 ± 2
% secretory 9 ± 1 8 ± 1
% basal 13 ± 2 12 ± 1
% undifferentiated 5 ± 1 5 ± 1
Alveolar macrophages
Total number recovered ×106 14 ± 1 32 ± 12
% alveolar macrophages after purification >97% >98%
1 Data are presented as mean ± standard error.
2 B = Black W = White H = Hispanic.
3 Venous carboxyhemoglobin, a secondary marker of current smoking; nonsmokers <1.5%.
4 FVC = forced vital capacity; FEV1 = forced expiratory volume in first second; DLCO = diffusion capacity for carbon monoxide; all data presented 
as % predicted except for FEV1/FVC presented as % observed.Respiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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were as expected from the small airways; there were no
differences in the subtypes of airway epithelial cells
among the nonsmokers and smokers (p > 0.1, all compar-
isons). Alveolar macrophages were obtained from the
same healthy nonsmokers and healthy smokers. Total
alveolar macrophage counts obtained ranged from 11.9 to
17.8 × 106 for the nonsmokers and 8.3 to 32.4 × 106 for
the healthy smokers; on average, more alveolar macro-
phages were recovered from healthy smokers than non-
smokers (p < 0.01). After purification, alveolar
macrophages from both groups were ≥97% pure.
Oxidant-related Gene Expression in Nonsmokers
To describe the expression patterns of oxidant-related
genes in small airway epithelium and alveolar macro-
phages, a list of 155 oxidant-related genes with probes on
the Affymetrix HG-U133 Plus 2.0 microarray was com-
piled from the literature and categorized by function or
pathway (Additional File 1). These genes included: glu-
tathione metabolism (35 genes), redox balance (3), cata-
lase/superoxide dismutase (4), oxidant scavengers (24),
pentose phosphate cycle (14), xenobiotic metabolism
(58), selenium-related (7), bilirubin-related (4), ascorbic
acid-related (2) and production of free radicals (4). Using
an expression criterion of having an Affymetrix Detection
Call of "Present" in ≥50% of individuals, genes from most
of these categories were expressed in both small airway
epithelium and alveolar macrophages of nonsmokers. Of
the total 155 oxidant-related genes surveyed in the non-
smokers, 87 genes (56%) were expressed in both cell types
(Additional File 1; Figure 1). There were 27 (17%) oxi-
dant-related genes expressed only in small airway epithe-
lium that were not expressed in alveolar macrophages of
nonsmokers; 21 (78%) of these genes were in the xenobi-
otic metabolism category and 4 (15%) genes were in the
glutathione metabolism category. However, there were
only 8 (5%) oxidant-related genes expressed in alveolar
macrophages that were not expressed in small airway epi-
thelium; 5 of these genes were in the xenobiotic metabo-
lism category. Among those genes uniquely expressed in
small airway epithelium were xenobiotic genes CYP4F3,
CYP4Z1, CYP7B1 and CYP39A1 that have not previously
been described as expressed in human airway epithelium.
Oxidant-related Gene Expression in Smokers
Of the 155 oxidant-related genes surveyed, there were 89
(57%) genes expressed in both the small airway epithe-
lium and alveolar macrophages of healthy smokers. Simi-
lar to healthy nonsmokers, there were 28 (18%) oxidant-
related genes expressed only in the small airway epithe-
lium of smokers and not expressed in alveolar macro-
phages from these same individuals. There were 5 (3%)
oxidant-related genes whose expression was unique to the
alveolar macrophages of smokers (Figure 1, Additional
File 1).
Differential Expression of Oxidant-related Genes in the 
Small Airway Epithelium and Alveolar Macrophages
While the majority of oxidant-related genes were
expressed in both alveolar macrophages and small airway
epithelium from healthy nonsmokers and healthy smok-
ers, there were marked differences in expression levels of
these genes between the two cell populations from these
same individuals.
In the nonsmokers there were 122 (78%) genes that were
expressed in either alveolar macrophages or small airway
epithelium, and 103 genes (67%) had differential expres-
sion (fold change >1.5, p < 0.05) between the two cell
populations. There were 37 (24%) genes with signifi-
cantly decreased expression in alveolar macrophages com-
pared to small airway epithelium, 24 of these were not
expressed at all in alveolar macrophages. However, 66
(43%) genes had higher expression levels in alveolar mac-
rophages compared to small airway epithelium in these
same nonsmokers and only 7 of these were explained by
absence of expression in small airway epithelium (Figure
1, Additional File 2, Additional File 3).
In healthy smokers, of the 123 genes that were expressed
in either alveolar macrophages or small airway epithe-
lium, there were 107 (69%) oxidant-related genes with
differential expression (fold change >1.5, p < 0.05)
between the two cell populations. There were 38 genes
(25%) with higher expression levels in airway epithelium
than in alveolar macrophages; 26 of these were explained
by the absence of expression in alveolar macrophages.
Similar to the nonsmokers, in the healthy smokers there
were 69 (45%) genes with higher expression in alveolar
macrophages compared to small airway epithelium. Only
6 of these genes lacked expression in small airway epithe-
lium (Figure 1, Additional File 4 and Additional File 5).
Overall there was higher expression in alveolar macro-
phages than in small airway epithelium for both non-
smokers and healthy smokers across all categories of
oxidant-related genes. This was particularly striking in the
categories of glutathione metabolism, redox balance and
other oxidant scavengers (Figure 2).
Smoking Responsive Oxidant-related Genes
There was a similar number of oxidant-related genes
expressed in small airway epithelium and alveolar macro-
phages of healthy nonsmokers and healthy smokers, but
there were marked differences in the pattern of genes that
were up- or down-regulated by smoking. Using a criterion
for smoking responsiveness of a statistically significant (p
< 0.05) fold-change (increase or decrease of ≥1.5) in
healthy smokers compared to nonsmokers, the expression
of 22 oxidant-related genes was up- or down-regulated in
the small airway epithelium and 5 genes were up- orRespiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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Expression of oxidant-related genes in small airway epithelium and alveolar macrophages of healthy nonsmokers and healthy  smokers Figure 1
Expression of oxidant-related genes in small airway epithelium and alveolar macrophages of healthy nonsmok-
ers and healthy smokers. A. Expression of oxidant-related genes in healthy nonsmokers. The % of all oxidant-related genes 
(total of 155 genes surveyed) that were expressed (defined as Affymetrix detection call of "present" in >50% of nonsmoker 
individuals, n = 19) is presented on the ordinate and the categories in which these genes are expressed are presented on the 
abscissa. Each bar represents the % of genes expressed and inside each bar is the corresponding number of oxidant-related 
genes expressed. B. Expression of oxidant-related genes in healthy smokers. The % of all oxidant-related genes that were 
expressed in healthy smokers (n = 30) is presented on the ordinate and the categories in which these genes are expressed is 
presented on the abscissa. Each bar represents the % of genes expressed and inside each bar is the corresponding number of 
oxidant-related genes expressed.
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Relative expression of oxidant-related genes in small airway epithelium compared to alveolar macrophages from the same  healthy nonsmokers and healthy smokers Figure 2
Relative expression of oxidant-related genes in small airway epithelium compared to alveolar macrophages 
from the same healthy nonsmokers and healthy smokers. Presented only are those oxidant-related genes expressed 
(Affymetrix detection call of present in >50% of small airway epithelium or alveolar macrophages) in healthy nonsmokers or 
healthy smokers. Average relative expression of oxidant-related genes in small airway epithelium is presented on the ordinate 
and average relative expression of oxidant-related genes in alveolar macrophages is presented on the abscissa. Each point rep-
resents one gene. white circle = average expression in healthy nonsmokers; black circle = average relative expression in 
healthy smokers. The different categories of oxidant-related genes surveyed are presented in panels A-H. A. Glutathione 
metabolism; B. Redox balance; C. Catalase/superoxide dismutases; D. Other oxidant scavengers; E. Pentose pathway cycle; F. 
Xenobiotic metabolism; G. Selenium-related; and H. Bilirubin/ascorbic acid related.
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down-regulated in alveolar macrophages (Figure 3, Tables
2, 3). In that context, the expression of 15 oxidant-related
genes was up-regulated in the small airway epithelium,
and only 1 of these genes was also up-regulated in alveolar
macrophages. In contrast, only 3 genes were up-regulated
by smoking in alveolar macrophages, with 2 of them
unique to alveolar macrophages. Seven genes were down-
regulated in the small airway epithelium of smokers; all of
these genes were uniquely down-regulated in small airway
epithelium, and an additional 2 genes were uniquely
down-regulated in alveolar macrophages from the same
individuals (Figure 4).
The differences between smokers and nonsmokers in the
response of the small airway epithelium and alveolar mac-
rophages were apparent when comparing the level of sta-
tistical significance (p value) and fold-change (up- or
down-regulated) with far more dramatic changes appar-
ent in the small airway epithelium. Whereas smoking-
induced down-regulation was observed in both small air-
way epithelium and alveolar macrophages, this direction
of response was far more common in the small airway epi-
thelium, with the major down-regulation of expression in
the category of oxidant scavengers (Figure 5, Table 2).
In the category of glutathione metabolism, 4 genes were
up-regulated in the small airway epithelium (p < 0.02),
but only one of these genes was also changed in alveolar
macrophages (glutamate cysteine ligase, catalytic subunit,
p < 0.01). Three genes were up-regulated in the redox bal-
ance category in small airway epithelium (p < 0.01), while
there were no genes from this category changed signifi-
cantly in alveolar macrophages. There were no changes in
catalase/superoxide dismutase gene expression in small
airway epithelium, but superoxide dismutase 2 was down-
regulated in alveolar macrophages of smokers (p < 0.01).
Interestingly, with regard to other oxidant scavengers, 5
genes were down-regulated in small airway epithelium
and 1 gene was up-regulated while there was no apparent
effect of smoking in this category in alveolar macro-
phages. Four genes from the pentose phosphate cycle were
either up-or down-regulated in healthy smokers com-
pared to nonsmokers in small airway epithelium (p <
0.01), but only 1 gene from this pathway changed signifi-
cantly in alveolar macrophages (protein kinase C alpha, p
< 0.04).
The expression of 5 genes involved in xenobiotic metabo-
lism was significantly different in healthy smokers com-
pared to healthy nonsmokers in small airway epithelium
(p < 0.05). Four genes were upregulated in the small air-
way epithelium of smokers, including cytochrome P450,
1B1 (p < 0.01). Three other xenobiotic metabolism genes
were also uniquely up-regulated in small airway epithe-
lium including cytochrome P450 4F3, 4F11 and 26A1 (p
< 0.05). There was 1 gene involved in xenobiotic metabo-
lism that was uniquely down-regulated in small airway
epithelium (cytochrome P450, 4X1, p < 0.001) and 1 gene
that was uniquely down-regulated in alveolar macro-
phages, (cytochrome P450, 3A7, p < 0.04). In the category
of bilirubin related genes, solute carrier 23A2 was
Smoking responsiveness of oxidant-related genes expressed  in the small airway epithelium and alveolar macrophages of  healthy nonsmokers (n = 19) and healthy smokers (n = 30) Figure 3
Smoking responsiveness of oxidant-related genes 
expressed in the small airway epithelium and alveo-
lar macrophages of healthy nonsmokers (n = 19) and 
healthy smokers (n = 30). A. Smoking responsiveness of 
expressed oxidant-related genes in small airway epithelium. 
B. Smoking responsiveness of expressed oxidant-related 
genes in alveolar macrophages. For both A and B, the ordi-
nate shows p value and the abscissa shows fold-change. Each 
data point represents 1 oxidant-related gene. Grey = oxi-
dant-related genes that are not significantly changed (p > 0.05 
and/or fold-change up or down <1.5) in small airway epithe-
lium or alveolar macrophages of normal smokers compared 
to normal nonsmokers. Blue = oxidant-related genes that are 
smoking responsive or significantly changed (p < 0.05, fold 
change up or down ≥1.5) in the small airway epithelium; red 
= oxidant-related genes that are smoking responsive or sig-
nificantly changed in alveolar macrophages of healthy smok-
ers compared to healthy nonsmokers.
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Percentage of the total of 155 oxidant-related genes surveyed that are smoking responsive in small airway epithelium and alve- olar macrophages Figure 4
Percentage of the total of 155 oxidant-related genes surveyed that are smoking responsive in small airway epi-
thelium and alveolar macrophages. A. Oxidant-related genes whose expression is up-regulated in healthy smokers com-
pared to healthy nonsmokers. B. Oxidant-related genes whose expression is down-regulated in healthy smokers compared to 
healthy nonsmokers. For both A and B, the percentage of oxidant-related genes up or down-regulated are presented on the 
ordinate and the different categories are presented on the abscissa; within each bar is the number of genes modified.
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Table 2: Smoking Responsive Oxidant-related Gene Expression in the Small Airway Epithelium1
Category Probe set ID Gene symbol Gene title Nonsmoker
% present2
Healthy smoker
% present
Smokers/
nonsmokers 
(fold-change)
p value
Glutathione 
metabolism
202275_at G6PD glucose-6-
phosphate 
dehydrogenase
42 77 1.78 0.015
202923_s_at GCLC glutamate-
cysteine ligase, 
catalytic subunit
100 100 1.50 0.005
202831_at GPX2 glutathione 
peroxidase 2
100 100 5.00 < 0.001
205770_at GSR glutathione 
reductase
100 100 1.60 0.013
Redox balance 210505_at ADH7 alcohol 
dehydrogenase 7, 
mu or sigma 
polypeptide
100 100 5.37 < 0.001
201272_at AKR1B1 aldo-keto reductase 
family 1, member 
B1
100 100 1.72 < 0.001
209160_at AKR1C3 aldo-keto reductase 
family 1, member 
C3
100 100 2.53 < 0.001
Catalase/SOD No smoking responsive genes in this category in small airway epithelium
Other oxidants 
scavengers
202018_s_at LTF lactotransferrin 100 87 -3.16 < 0.001
212859_x_at MT1E metallothionein 1E 100 100 -1.75 < 0.001
213629_x_at MT1F metallothionein 1F 100 100 -2.00 < 0.001
208581_x_at MT1X metallothionein 1X 100 100 -1.56 0.002
212185_x_at MT2A metallothionein 2A 100 100 -1.64 0.001
201266_at TXNRD1 thioredoxin 
reductase 1
100 100 1.87 < 0.001
Pentose phosphate 
cycle
201118_at PGD phosphogluconate 
dehydrogenase
100 100 1.66 0.008
213093_at PRKCA protein kinase C, 
alpha
100 100 -1.52  < 0.001
201463_s_at TALDO1 transaldolase 1 100 100 1.61 0.001
208699_x_at TKT transketolase 100 100 1.79 0.008
Xenobiotic 
metabolism
202437_s_at CYP1B1 cytochrome P450, 
family 1, subfamily 
B, polypeptide 1
32 97 25.41 < 0.001
206515_at CYP4F3 cytochrome P450, 
family 4, subfamily F, 
polypeptide 3
95 93 2.27 0.001
206153_at CYP4F11 cytochrome P450, 
family 4, subfamily F, 
polypeptide 11
79 90 3.21 0.013
227702_at CYP4X1 cytochrome P450, 
family 4, subfamily 
X, polypeptide 1
100 100 -2.02 < 0.001
206424_at CYP26A1 cytochrome P450, 
family 26, subfamily 
A, polypeptide 1
37 63 2.05 0.045
Bilirubin related No smoking responsive genes in this category in small airway epithelium
Ascorbic acid 
related
No smoking responsive genes in this category in small airway epithelium
Production of free 
radicals
No smoking responsive genes in this category in small airway epithelium
1 Smoking responsive genes defined as fold-change smokers compared to nonsmokers >1.5 and p value < 0.05 in genes expressed in >50% of either 
nonsmokers or smokers. Bold type represents differentially expressed genes in both small airway epithelium and alveolar macrophages 
(see Table 3).
2 % present refers to Affymetrix Detection Call of Present as a % of total numbers of healthy nonsmokers (n = 19) and healthy smokers (n = 30).Respiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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uniquely up-regulated in alveolar macrophages (p <
0.04).
The gene expression pattern of 2 oxidant-related genes
was altered in both the small airway epithelium and alve-
olar macrophages; glutamate cysteine ligase (p < 0.01 for
both cell types) and protein kinase C alpha (p < 0.01 for
both cell types, Figure 5). Interestingly, protein kinase C
alpha, a member of the pentose phosphate cycle, was
down-regulated in small airway epithelium of healthy
smokers (1.5-fold decrease, p < 0.01) but up-regulated in
alveolar macrophages of healthy smokers (1.9-fold
increase, p < 0.04; Figure 5).
TaqMan RT-PCR Confirmation of Microarray Gene 
Expression
To validate the results obtained from the microarray, Taq-
Man RT-PCR was carried out to assess several genes using
RNA samples from healthy nonsmokers (n = 6) and
healthy smokers (n = 6). In the small airway epithelium,
TaqMan RT-PCR confirmed the up-regulation of alcohol
dehydrogenase 7 (6.2 fold increase, p < 0.02), glutathione
peroxidase 2 (3.9 fold increase, p < 0.01), cytochrome
P450 1B1 (36.7 fold increase, p < 0.03) and down-regula-
tion of metallothionein 1F (2.3 fold decrease, p < 0.05).
In alveolar macrophages, TaqMan RT-PCR confirmed the
down-regulation of superoxide dismutase 2 (3.6 fold
decrease, p < 0.03) and the up-regulation of glutamate
cysteine ligase catalytic subunit (3.4 fold increase, p <
0.01) and protein kinase C alpha (4.2 fold increase, p <
0.01, Table 4).
Functional Pathway Assessment
To further assess the response of small airway epithelium
and alveolar macrophages from the same individuals to
cigarette smoke, all smoking responsive genes were exam-
ined using functional analysis software. In total, there
were 297 smoking responsive genes in small airway epi-
thelium and 116 smoking responsive genes in alveolar
macrophages. Overall, the main pathways affected by
smoking were related to xenobiotic metabolism and oxi-
dant response in small airway epithelium while oxidation
pathways did not feature as being enriched in alveolar
macrophages (Table 5). The main canonical pathways
affected in small airway epithelium were metabolism of
xenobiotics by cytochrome p450 [ratio (number of path-
way genes in the smoking responsive data set compared to
the total number of genes in the pathway) 0.047, p <
0.001], xenobiotic metabolism signaling (ratio 0.048, p <
0.001), arachidonic acid metabolism (ratio 0.038, p <
0.001), pentose and glucuronate interconversions (ratio
0.047, p < 0.001) and glutathione metabolism (ratio
0.048, p < 0.001). In contrast, the main canonical path-
ways affected in alveolar macrophages were IL-10 signal-
ing (ratio 0.07, p < 0.001), peroxisome proliferator
activator receptor alpha (PPARa)/retinoid × receptor
Table 3: Smoking Responsive Oxidant-related Gene Expression in Alveolar Macrophages1
Category Probe set ID Gene symbol Gene title Nonsmokers
% present2
Healthy 
smokers
% present
Smokers/non-
smokers 
(fold-change)
p value
Glutathione 
metabolism
202923_s_at GCLC glutamate-
cysteine ligase, 
catalytic subunit
100 100 1.67 0.007
Redox balance No smoking responsive genes in this category in the alveolar macrophages
Catalase/SOD 216841_s_at SOD2 superoxide 
dismutase 2
100 100 -2.06 0.006
Oxidant 
scavengers
No smoking responsive genes in this category in the alveolar macrophages
Pentose 
phosphate cycle
213093_at PRKCA protein kinase C, 
alpha
95 100 1.86 0.037
Xenobiotic 
metabolism
205939_at CYP3A7 cytochrome P450, 
family 3, subfamily 
A, polypeptide 7
58 10 -3.69 0.030
Bilirubin related 209236_at SLC23A2solute 
carrier family 23, 
member 2
89 100 1.50 0.038
Ascorbic acid 
related
No smoking responsive genes in this category in the alveolar macrophages
Production of 
free radicals
No smoking responsive genes in this category in the alveolar macrophages
1 Smoking responsive genes defined as fold-change smokers compared to nonsmokers >1.5 and p value < 0.05 in genes expressed in >50% of either 
nonsmokers or smokers. Bold type represents differentially expressed genes in both small airway epithelium and alveolar macrophages 
(see Table 2).
2 % present refers to Affymetrix Detection Call of Present as a % of total numbers of healthy nonsmokers (n = 19) and healthy smokers (n = 30).Respiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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Comparison of the fold-changes of smoking responsive oxidant-related genes in the small airway epithelium and alveolar mac- rophages in the different oxidant-related gene categories Figure 5
Comparison of the fold-changes of smoking responsive oxidant-related genes in the small airway epithelium 
and alveolar macrophages in the different oxidant-related gene categories. A. Fold-change of smoking responsive 
oxidant-related genes in small airway epithelium. B. Fold-change of smoking responsive oxidant-related genes in alveolar mac-
rophages. For both A and B, the fold-change is presented on the ordinate and the oxidant-related genes in their categories on 
the abscissa. Each bar represents the fold-change (average expression in healthy smokers compared to average expression in 
healthy nonsmokers) of an oxidant related gene in the corresponding category and error bars represent the standard error for 
the ratio.
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alpha (RXRa, ratio 0.038, p < 0.001), liver × receptor/RXR
activation (ratio 0.059, p < 0.001), acute phase signaling
(ratio 0.04, p < 0.001) and hepatic cholestasis (ratio
0.036, p < 0.001).
Discussion
Cigarette smoking delivers a large oxidant burden to the
epithelial surface of the lung, with consequent changes in
the function of the epithelium and alveolar macrophages
[2,3]. There are extensive data implicating airway epithe-
lial cells and alveolar macrophages in the development of
COPD, but their roles are very different [2,3,11,12]. Given
that small airway epithelium becomes disorganized and
dysfunctional in response to cigarette smoking
[12,14,17], while alveolar macrophages become activated
[10,19,20], we asked the question; are there differences in
the gene expression patterns of oxidant-related genes in
the small airway epithelium and alveolar macrophages of
the same individuals and how do these different cell pop-
ulations respond to the oxidant stress of smoking? Using
microarray assessment the data demonstrates that the
majority of oxidant-related genes are expressed in both
cell types from the same individuals, but overall, the
expression level of oxidant-related genes is higher in alve-
olar macrophages than small airway epithelium. Interest-
ingly, however, airway epithelial cells show a much
greater response to smoke exposure than alveolar macro-
phage cells. While cigarette smoking is associated with
many significant differences in the expression of oxidant-
related genes in small airway epithelial cells there are
fewer smoking-related differences in oxidant-related gene
expression in alveolar macrophages. These observations
are consistent with the concept that the small airway epi-
thelium is more responsive to the oxidant stimulus of cig-
arette smoke than alveolar macrophages, and consistent
with the clinical observation that the small airway epithe-
lium is associated with the earliest morphologic changes
associated with smoking, whereas smoking does not cause
"disease" of alveolar macrophages.
Expression of Oxidant-related Genes
There are more oxidant-related genes expressed in the
small airway epithelium than in alveolar macrophages of
nonsmokers and smokers. Most of the uniquely expressed
genes in the small airway epithelium relate to glutathione
and xenobiotic metabolism, underlining the greater anti-
oxidant and detoxifying role of the small airway epithe-
lium. Within the category of xenobiotic metabolism there
are a number of genes expressed that have not previously
been described in human lung epithelium including
CYP4F3, which is up-regulated by smoking in small air-
way epithelium. Interestingly, this cytochrome enzyme
Table 4: TaqMan RT-PCR Confirmation of Smoking Responsive Genes in Small Airway Epithelium and Alveolar Macrophages
Small airway epithelium Alveolar macrophages
Gene Fold-change1 p value2 Gene Fold-change p value
Alcohol dehydrogenase 7 6.2 < 0.02 Superoxide dismutase 2 -3.6 < 0.03
Glutathione peroxidase 2 3.9 < 0.01 Glutamate cysteine ligase C 3.8 < 0.01
Metallothionein 1F -2.3 < 0.05 Protein kinase C alpha 4.2 < 0.01
Cytochrome P450 1B1 36.7 < 0.03
1 Fold change is calculated as the average expression level in healthy smokers (n = 6) compared to the average expression level in healthy 
nonsmokers (n = 6).
2 p value calculated using an unpaired t test assuming unequal variance.
Table 5: Pathway Analysis of Smoking Responsive Genes in Small Airway Epithelium and Alveolar Macrophages1
Small airway epithelium Alveolar macrophages
Functional pathway Ratio2 p value Functional pathway Ratio p value
Xenobiotic metabolism 0.05 < 0.001 IL-10 signaling 0.07 < 0.001
Xenobiotic signaling 0.05 < 0.001 Peroxisome proliferator activator pathway/retinoic acid × 
receptor activation
0.04 < 0.001
Arachidonic acid metabolism 0.04 < 0.001 Liver × receptor activation pathway 0.06 < 0.001
Pentose and glucuronate interconversions 0.03 < 0.001 Acute phase signaling pathway 0.04 < 0.001
Glutathione metabolism 0.05 < 0.001 Hepatic cholestasis 0.04 < 0.001
1 Functional pathway analysis was carried out using Ingenuity Pathway Analysis http://www.ingenuity.com on all smoking responsive (fold-change 
healthy smokers compared to healthy nonsmokers >1.5, p < 0.05 following Benjamini-Hochberg multiple test correction) genes in small airway 
epithelium and alveolar macrophages from the same healthy nonsmokers (n = 19) and healthy smokers (n = 30). Canonical pathways were selected 
on the basis of significance and ratio
2 Ratio refers to the number of pathway genes in the smoking responsive dataset compared to the total number of genes in the curated pathway.Respiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
Page 14 of 17
(page number not for citation purposes)
plays a role in the inactivation of leukotriene B4, a potent
chemotaxin in the lung [27]. Based on the knowledge that
xenobiotic metabolism represents an activating step in a
number of pro-inflammatory and pro-carcinogen compo-
nents of cigarette smoke, the finding of increased expres-
sion of cytochrome P450 enzymes in small airway
epithelium compared to alveolar macrophages from the
same individuals is consistent with the concept that the
earliest site of disease in COPD is in the small airways
[12,14].
Within an individual, the majority of the oxidant-related
genes that are expressed in both cell populations are
expressed at much higher levels in alveolar macrophages
compared to small airway epithelium. Macrophages are
responsive to low levels of oxidants, using them in signal
transduction to activate transcription [28]. Given that
alveolar macrophages use reactive oxygen species in the
respiratory burst during phagocytosis [29], it may be
important for cytoprotection to express high baseline lev-
els of antioxidants in situations where endogenous oxi-
dants pose a threat, thus rendering them less responsive to
exogenous oxidant stress. However, when exposed to high
concentrations of exogenous oxidants the oxidant/anti-
oxidant imbalance can lead to stimulation of cell surface
receptors which activate the inflammatory response in
macrophages through activation of nuclear factor kappa
B, mitogen activated protein kinase and activator protein
1 pathways further damaging the lung [28].
Smoking Responsive Oxidant-related Genes
When examining the effects of smoking on oxidant-
related gene expression there are far more differences in
oxidant-related gene expression in small airway epithe-
lium of healthy smokers compared to healthy nonsmok-
ers than in alveolar macrophages from the same
individuals. This suggests that the small airway epithe-
lium may be more responsive to the oxidant burden of
cigarette smoke than alveolar macrophages. Alveolar mac-
rophages exhibit fewer changes in oxidant-related gene
expression than airway epithelium; while this may be an
artifact of the small sample size of individuals, it may also
be because they are constantly being replaced in lung tis-
sue and their cumulative exposure to oxidant stress may
be less. However, the lifespan of an alveolar macrophage
is a matter of debate, but these cells may reside in the lung
for a relatively long period of time (months) and therefore
have a similar turnover to small airway epithelium [29-
31]. Another consideration is the physical location of
alveolar macrophages, which reside primarily on the alve-
olar surface; thus, they are exposed to a more diluted form
of cigarette smoke, being further away from the initial
inhalation than airway epithelium. However, this is not
the case when examining global changes in gene expres-
sion in alveolar macrophages where there are many
changes across various categories of genes in healthy ciga-
rette smokers [17,19]. An alternative explanation is that
alveolar macrophages are relatively less responsive than
small airway epithelium to exogenous oxidants. Consist-
ent with this concept, primary human and murine alveo-
lar macrophages are much less responsive to the pro-
oxidant and pro-inflammatory effects of diesel exhaust
particles than airway epithelial cell lines and normal
human bronchial epithelial cells [32]. While epithelial
cells more rapidly transitioned from a cytoprotective to
cytotoxic response, alveolar macrophages responded in a
hierarchal fashion, able to withstand higher concentra-
tions of exogenous oxidants. This inherent resistance to
oxidative stress in alveolar macrophages may be related to
their ability to convert N-acetylcysteine to cytoprotective
glutathione which epithelial cells cannot do [32]. In other
studies, the in vitro response of rat alveolar macrophages
and type II epithelial cells to paraquat exposure (a herbi-
cide that injures lung cells by oxidant-related mechanisms
including DNA strand breaks) showed significantly higher
DNA strand breaks in type II epithelial cells compared to
alveolar macrophages, suggesting that alveolar macro-
phages may have better intrinsic antioxidant mechanisms
and/or have more efficient repair mechanisms following
oxidant injury than epithelial cells [33]. These studies,
together with the present study of in vivo cigarette smoking
in humans, suggest that the available transcriptome of
alveolar macrophages is relatively less sensitive than that
of the small airway epithelium to the oxidant stress of cig-
arette smoke.
Categories of Smoking-responsive Oxidant-related Genes
A similar number of the surveyed oxidant-related genes
are expressed in both small airway epithelium and alveo-
lar macrophages However, only the small airway epithe-
lium responds to cigarette smoke by altering the gene
expression profile of key pathways including glutathione
metabolism, pentose phosphate cycle, redox balance and
oxidant scavengers.
Glutathione is a ubiquitous tripeptide with a sulfhydryl
group that enables it to protect cells from oxidant damage,
and therefore serves as a major antioxidant in the lungs
[9]. Glutathione homeostasis is regulated by glutathione
cysteine ligase (GCLC) and the glutathione redox system.
Consistent with previous studies, we observed increased
gene expression of many enzymes involved in glutathione
metabolism, including GCLC, in airway epithelium of
healthy smokers [15,18]. Related to this is the pentose
phosphate cycle, which produces reducing equivalents in
the form of NADPH necessary for the generation of
reduced glutathione [34]. Similar to what we observed,
glucose-6 phosphate dehydrogenase and phosphogluco-
nate dehydrogenase are also induced in rabbit lung fol-
lowing oxidant injury, indicating that these enzymes playRespiratory Research 2009, 10:111 http://respiratory-research.com/content/10/1/111
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a role in the regenerative response following acute oxidant
injury [35]. While there are no studies currently linking
members of the pentose phosphate cycle to the pathogen-
esis of COPD, protein kinase C alpha subunit (PRKCA) is
down-regulated in small airway epithelium of smokers
but up-regulated in alveolar macrophages from the same
individuals. PRKC increases activation of nuclear factor
erythroid 2-related factor 2 (NRF2), an oxidant respond-
ing transcription factor known to induce phase 2 detoxify-
ing and antioxidant gene expression to protect cells from
oxidative stress [36]. Studies have shown decreased NRF2
protein in the lungs of smokers who develop COPD [37],
and in alveolar macrophages from smokers with emphy-
sema [38].
In the category of oxidant scavengers, the expression of a
number of metallothioneins is down-regulated in small
airway epithelium in response to smoking. Overexpres-
sion of metallothioneins decreases sensitivity of pulmo-
nary endothelial cells to oxidant injury [39], and while
increased expression occurs in rat bronchial epithelial
cells in response to acute cigarette smoke exposure, the
effect is attenuated by chronic smoke exposure [39,40]. In
our study, and consistent with other studies, decreased
gene expression of metallothioneins in chronic healthy
smokers may contribute to making the epithelium more
vulnerable to oxidative damage than alveolar macro-
phages [16].
Superoxide dismutases are scavengers of free radicals
within the cell. In alveolar macrophages superoxide dis-
mutase 2 is down-regulated by smoking. There is conflict-
ing evidence regarding the effects of smoking on SOD2,
with some studies demonstrating up-regulation in smok-
ers and others demonstrating down-regulation of the
SOD2 protein, including down-regulation of expression
in alveolar macrophages of healthy smokers compared to
nonsmokers [41-43].
Functional Pathway Assessment
Functional pathway analysis of all smoking responsive
genes in small airway epithelium and alveolar macro-
phages revealed that the dominant canonical pathways
affected by smoking in small airway epithelium were
related to detoxifying and oxidant responses. However, IL-
10, peroxisome proliferator activator receptor (PPAR) and
liver × receptor pathways (LXR), are the top three path-
ways enriched in alveolar macrophages of healthy smok-
ers. IL-10 plays a role in immune tolerance and pathogen
clearance [44], PPAR down-regulates the synthesis of
immunomodulatory cytokines and PPAR agonists may
have a protective role in oxidative stress [45], while LXR
inhibits macrophage responses to bacterial pathogens and
antagonizes a number of pro-inflammatory cytokines
[46]. These functional pathway data are further confirma-
tion of the hypothesis that the small airway epithelium is
the main site of oxidant response in the lung while the
oxidant response of alveolar macrophages is relatively less
given the same in vivo stress of cigarette smoking.
Overall, the present study demonstrates that while there
are differences in the expression of many relevant oxidant-
related genes in the small airway epithelium of smokers
compared to nonsmokers, there are far fewer differences
in gene expression in alveolar macrophages. These find-
ings support the notion that alveolar macrophages are not
"diseased" in the lungs of smokers. On the other hand,
changes in small airway epithelium gene expression are a
harbinger of smoking-related disease and these cells
become deranged and disorganized in smoke-exposed
individuals. The observation of differential responses of
these two cell types to cigarette smoke exposure is consist-
ent with this explanation.
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